10 core suite software seqman pro Search Results


97
DNASTAR seqman
Seqman, supplied by DNASTAR, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10+core+suite+software+seqman+pro/SeqMan+Pro/10__17582_slash_journal__pjz_slash_20220824110811-48-8-11
Average 97 stars, based on 1 article reviews
seqman - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

99
DNASTAR lasergene seqman pro software
Lasergene Seqman Pro Software, supplied by DNASTAR, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10+core+suite+software+seqman+pro/Lasergene/pm27016831-99-5-6
Average 99 stars, based on 1 article reviews
lasergene seqman pro software - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
SeqMatic LLC indexed phix control library
Indexed Phix Control Library, supplied by SeqMatic LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10+core+suite+software+seqman+pro/tailormix+indexed+phix+control+library/pmc04611039__mbo005152470s2-13-16-23
Average 90 stars, based on 1 article reviews
indexed phix control library - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

97
DNASTAR seqman ngen
Seqman Ngen, supplied by DNASTAR, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10+core+suite+software+seqman+pro/SeqMan+NGen/pmc03836461-59-17-21
Average 97 stars, based on 1 article reviews
seqman ngen - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

90
SeqMatic LLC v(d)j enrichment
Molecular design and characterization of AB248, a CD8 cis -targeted IL2. A, Overview of the objectives for a CD8 + T-cell cis -targeted IL2 molecule. B and C, Human PBMCs were assessed for expression of CD8α and CD8β by flow cytometry ( n = 10). Shown are the constituent cell types for CD8α + or CD8β + lymphocytes by percentage ( B ), and the percentage staining positive for CD8α or CD8β within the indicated cellular subsets ( C ). D, Overview of the molecular characteristics of the development candidate AB248. E, pSTAT5 was assessed by flow cytometry following a 25-minute stimulation of human blood with rhIL2, CTRL-not-α-hIL2, or AB248 ( n = 10). F and G, Human CD8 + T-cell subsets were flow sorted from peripheral blood and cultured for 24 hours with AB248, rhIL2, or media, and transcriptional changes were analyzed via <t>RNA-seq.</t> Shown is the sorting strategy for a representative donor ( F ) and gene expression (by average log 2 fold changes of cpm) over media control. APC; antigen presenting cell. ( G ) with each differentially expressed gene represented by a point. P value cutoffs of 0.2 are applied to fold change data. A reference dashed line with a slope of 1 is shown; R is the correlation coefficient from the linear regression model ( n = 3 donors). H and I, human PBMCs were cultured with the indicated concentrations of rhIL2, CTRL-not-α-hIL2, or AB248 for 5 days and Ki-67 expression was assessed by flow cytometry. Shown is Ki-67 staining in one representative donor at 10 nmol/L ( H ) and Ki-67 expression (%) within the indicated cell subsets as a function of concentration (I; n = 2). J, Isolated peripheral blood CD8 + T cells were incubated with AB248 for 48 hours in the presence or absence of suboptimal TransAct CD3/CD28 stimulation (1:10,000) and supernatant IFNγ and TNFα were quantified using MSD ( n = 5). Studies are representative of 2–3 independent experiments.
V(d)j Enrichment, supplied by SeqMatic LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10+core+suite+software+seqman+pro/v+d+j+enrichment/pmc11215410-326-12-4
Average 90 stars, based on 1 article reviews
v(d)j enrichment - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Molecular design and characterization of AB248, a CD8 cis -targeted IL2. A, Overview of the objectives for a CD8 + T-cell cis -targeted IL2 molecule. B and C, Human PBMCs were assessed for expression of CD8α and CD8β by flow cytometry ( n = 10). Shown are the constituent cell types for CD8α + or CD8β + lymphocytes by percentage ( B ), and the percentage staining positive for CD8α or CD8β within the indicated cellular subsets ( C ). D, Overview of the molecular characteristics of the development candidate AB248. E, pSTAT5 was assessed by flow cytometry following a 25-minute stimulation of human blood with rhIL2, CTRL-not-α-hIL2, or AB248 ( n = 10). F and G, Human CD8 + T-cell subsets were flow sorted from peripheral blood and cultured for 24 hours with AB248, rhIL2, or media, and transcriptional changes were analyzed via RNA-seq. Shown is the sorting strategy for a representative donor ( F ) and gene expression (by average log 2 fold changes of cpm) over media control. APC; antigen presenting cell. ( G ) with each differentially expressed gene represented by a point. P value cutoffs of 0.2 are applied to fold change data. A reference dashed line with a slope of 1 is shown; R is the correlation coefficient from the linear regression model ( n = 3 donors). H and I, human PBMCs were cultured with the indicated concentrations of rhIL2, CTRL-not-α-hIL2, or AB248 for 5 days and Ki-67 expression was assessed by flow cytometry. Shown is Ki-67 staining in one representative donor at 10 nmol/L ( H ) and Ki-67 expression (%) within the indicated cell subsets as a function of concentration (I; n = 2). J, Isolated peripheral blood CD8 + T cells were incubated with AB248 for 48 hours in the presence or absence of suboptimal TransAct CD3/CD28 stimulation (1:10,000) and supernatant IFNγ and TNFα were quantified using MSD ( n = 5). Studies are representative of 2–3 independent experiments.

Journal: Cancer Discovery

Article Title: IL2 Targeted to CD8 + T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity

doi: 10.1158/2159-8290.CD-23-1266

Figure Lengend Snippet: Molecular design and characterization of AB248, a CD8 cis -targeted IL2. A, Overview of the objectives for a CD8 + T-cell cis -targeted IL2 molecule. B and C, Human PBMCs were assessed for expression of CD8α and CD8β by flow cytometry ( n = 10). Shown are the constituent cell types for CD8α + or CD8β + lymphocytes by percentage ( B ), and the percentage staining positive for CD8α or CD8β within the indicated cellular subsets ( C ). D, Overview of the molecular characteristics of the development candidate AB248. E, pSTAT5 was assessed by flow cytometry following a 25-minute stimulation of human blood with rhIL2, CTRL-not-α-hIL2, or AB248 ( n = 10). F and G, Human CD8 + T-cell subsets were flow sorted from peripheral blood and cultured for 24 hours with AB248, rhIL2, or media, and transcriptional changes were analyzed via RNA-seq. Shown is the sorting strategy for a representative donor ( F ) and gene expression (by average log 2 fold changes of cpm) over media control. APC; antigen presenting cell. ( G ) with each differentially expressed gene represented by a point. P value cutoffs of 0.2 are applied to fold change data. A reference dashed line with a slope of 1 is shown; R is the correlation coefficient from the linear regression model ( n = 3 donors). H and I, human PBMCs were cultured with the indicated concentrations of rhIL2, CTRL-not-α-hIL2, or AB248 for 5 days and Ki-67 expression was assessed by flow cytometry. Shown is Ki-67 staining in one representative donor at 10 nmol/L ( H ) and Ki-67 expression (%) within the indicated cell subsets as a function of concentration (I; n = 2). J, Isolated peripheral blood CD8 + T cells were incubated with AB248 for 48 hours in the presence or absence of suboptimal TransAct CD3/CD28 stimulation (1:10,000) and supernatant IFNγ and TNFα were quantified using MSD ( n = 5). Studies are representative of 2–3 independent experiments.

Article Snippet: Samples were submitted to SeqMatic to generate 10x libraries using 10 × 5′v2 Single-Cell RNA-seq, V(D)J enrichment and feature barcoding.

Techniques: Expressing, Flow Cytometry, Staining, Cell Culture, RNA Sequencing Assay, Control, Concentration Assay, Isolation, Incubation